Dermata Therapeutics Files 8-K Report
Ticker: DRMAW · Form: 8-K · Filed: Mar 27, 2025 · CIK: 1853816
| Field | Detail |
|---|---|
| Company | Dermata Therapeutics, Inc. (DRMAW) |
| Form Type | 8-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-statements, regulation-fd
Related Tickers: DRMA
TL;DR
DRMA filed an 8-K. Check for financial updates.
AI Summary
On March 27, 2025, Dermata Therapeutics, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulation FD disclosure. No specific financial figures or significant corporate actions were detailed in the provided text.
Why It Matters
This filing indicates Dermata Therapeutics is providing updated information to the SEC, which could include financial details or other material events relevant to investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report without immediate indication of significant negative events.
Key Players & Entities
- Dermata Therapeutics, Inc. (company) — Registrant
- March 27, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 3525 Del Mar Heights Rd., #322, San Diego, CA 92130 (address) — Principal executive offices
FAQ
What specific financial statements are included in this 8-K filing?
The provided text indicates that 'Financial Statements and Exhibits' are part of the filing, but does not specify which ones.
What 'Other Events' are being reported by Dermata Therapeutics?
The filing lists 'Other Events' as an item information category, but the specific events are not detailed in the provided text.
What is the significance of the 'Regulation FD Disclosure' mentioned in the filing?
A Regulation FD Disclosure indicates that the company is making public disclosures to prevent selective disclosure of material non-public information.
When was Dermata Therapeutics incorporated?
Dermata Therapeutics, Inc. was incorporated in Delaware.
What is the principal business address of Dermata Therapeutics?
The principal executive offices are located at 3525 Del Mar Heights Rd., #322, San Diego, CA 92130.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 27, 2025 regarding Dermata Therapeutics, Inc. (DRMAW).